Brain Tumor Immunotherapy: What have We Learned so Far?

por Van Gool, Stefaan Willy
Publicado 2015

Dendritic cell-based immunotherapy in ovarian cancer

por Coosemans, An, Vergote, Ignace, Van Gool, Stefaan W
Publicado 2013

Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy

por Schirrmacher, Volker, van Gool, Stefaan, Stuecker, Wilfried
Publicado 2019

Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy

por Schirrmacher, Volker, van Gool, Stefaan, Stuecker, Wilfried
Publicado 2022

Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response

por Dejaegher, Joost, Van Gool, Stefaan, De Vleeschouwer, Steven
Publicado 2014

Evidence-Based Medicine in Oncology: Commercial Versus Patient Benefit

por Schirrmacher, Volker, Sprenger, Tobias, Stuecker, Wilfried, Van Gool, Stefaan W.
Publicado 2020

Depletion of Regulatory T Cells in a Mouse Experimental Glioma Model through Anti-CD25 Treatment Results in the Infiltration of Non-Immunosuppressive Myeloid Cells in the Brain

por Maes, Wim, Verschuere, Tina, Van Hoylandt, Anaïs, Boon, Louis, Van Gool, Stefaan
Publicado 2013

Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells

por Jacobs, Sandra A, Roobrouck, Valerie D, Verfaillie, Catherine M, Van Gool, Stefaan W
Publicado 2013

Immune Suppression during Oncolytic Virotherapy for High-Grade Glioma; Yes or No?

por Koks, Carolien A.E., De Vleeschouwer, Steven, Graf, Norbert, Van Gool, Stefaan W.
Publicado 2015

Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines

por Vandenberk, Lien, Belmans, Jochen, Van Woensel, Matthias, Riva, Matteo, Van Gool, Stefaan W.
Publicado 2016

Human CD4+CD25+ Regulatory T Cells Are Sensitive to Low Dose Cyclophosphamide: Implications for the Immune Response

por Heylmann, Daniel, Bauer, Martina, Becker, Huong, van Gool, Stefaan, Bacher, Nicole, Steinbrink, Kerstin, Kaina, Bernd
Publicado 2013

IMMU-02. CMV-EXPANDED T-CELLS IN GLIOBLASTOMA PATIENTS: TRANSLATIONAL RESEARCH

por Kampers, Linde F C, Rajabpour, Golnaz, Bitar, Michael, Schirrmacher, Volker, Stücker, Wilfried, Van Gool, Stefaan W
Publicado 2023

Immunotherapy with subcutaneous immunogenic autologous tumor lysate increases murine glioblastoma survival

por Belmans, Jochen, Van Woensel, Matthias, Creyns, Brecht, Dejaegher, Joost, Bullens, Dominique M., Van Gool, Stefaan W.
Publicado 2017

Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged

por Van Gool, Stefaan W., Makalowski, Jennifer, Fiore, Simon, Sprenger, Tobias, Prix, Lothar, Schirrmacher, Volker, Stuecker, Wilfried
Publicado 2020

Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients

por Van Gool, Stefaan W., Makalowski, Jennifer, Bitar, Michael, Van de Vliet, Peter, Schirrmacher, Volker, Stuecker, Wilfried
Publicado 2022

Irradiation of necrotic tumor cells used to pulse dendritic cells (DCs) potentiates DC vaccine-induced anti-tumor immunity in a mouse model of high-grade glioma

por Vandenberk, Lien, Garg, Abhishek D, Agostinis, Patrizia, Verschuere, Tina, Koks, Carolien, De Vleeschouwer, Steven, Van Gool, Stefaan
Publicado 2014

Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience

por Van Gool, Stefaan W., Makalowski, Jennifer, Van de Vliet, Peter, Van Gool, Stefanie, Sprenger, Tobias, Schirrmacher, Volker, Stuecker, Wilfried
Publicado 2023

The Application of Evidence-Based Medicine in Individualized Medicine

por Van de Vliet, Peter, Sprenger, Tobias, Kampers, Linde F. C., Makalowski, Jennifer, Schirrmacher, Volker, Stücker, Wilfried, Van Gool, Stefaan W.
Publicado 2023

Dendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached?

por Van Gool, Stefaan W., Makalowski, Jennifer, Kampers, Linde F. C., Van de Vliet, Peter, Sprenger, Tobias, Schirrmacher, Volker, Stücker, Wilfried
Publicado 2023

Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?

por van Woensel, Matthias, Wauthoz, Nathalie, Rosière, Rémi, Amighi, Karim, Mathieu, Véronique, Lefranc, Florence, van Gool, Stefaan W., de Vleeschouwer, Steven
Publicado 2013